Macrobiological features have been cited as irreducibly complex, including animal joints and the trap mechanisms of carnivorous plants, even the cell itself.

Source

In a recent study, scientists devised a way of reversing the buildup of compounds that lead to some age-related diseases.

In a groundbreaking study set to redefine our understanding of colorectal cancer progression, researchers have uncovered a critical molecular mechanism involving the RNA binding motif protein 41 (RBM41). This protein, previously underappreciated in oncogenic pathways, has now been identified as a potent facilitator of colorectal tumorigenesis through its interference with the maturation process of the NDRG1 pre-mRNA. The revelation not only elaborates the intricate post-transcriptional regulatory networks at play in cancer biology but also opens promising avenues for targeted therapeutic interventions.

Colorectal cancer remains one of the leading causes of cancer-related mortality worldwide, with complex layers of genetic and epigenetic dysregulations contributing to its development. The recent findings surrounding RBM41 spotlight a novel post-transcriptional checkpoint that is hijacked during malignant transformation. Normally, the maturation of pre-mRNA transcripts into functional messenger RNA is meticulously controlled, ensuring precise expression of genes pivotal for cellular homeostasis. The disruption of this process, as mediated by RBM41’s aberrant binding activity, skews the expression landscape in favor of tumorigenesis.

At the molecular level, RBM41 executes its oncogenic role by binding selectively to the pre-mRNA transcript of NDRG1, a known tumor suppressor gene implicated in inhibiting metastasis and promoting cellular differentiation. By impeding NDRG1 pre-mRNA maturation, RBM41 effectively reduces the levels of functional NDRG1 protein within colorectal cancer cells. This protein depletion dismantles critical tumor-suppressive barriers, allowing unchecked cellular proliferation and enhanced invasive capabilities that are hallmark features of aggressive cancer phenotypes.

The study’s rigorous experimental design combined comprehensive transcriptomic analyses with in vitro and in vivo functional assays. Data revealed a pronounced elevation of RBM41 expression in colorectal tumor samples compared to normal adjacent tissues. This upregulation correlates strongly with poor patient prognosis, underscoring the clinical relevance of RBM41 as a potential prognostic biomarker. Furthermore, silencing RBM41 expression in cancer cell lines reinstated normal NDRG1 protein levels, resulting in marked reductions in cell proliferation and migration.

One of the most compelling aspects of this research lies in the detailed mechanistic dissection of RBM41’s interaction with NDRG1 pre-mRNA. Using cross-linking immunoprecipitation followed by high-throughput sequencing, the authors mapped the precise binding sites of RBM41 on NDRG1 transcripts. These sites reside within critical regulatory regions essential for splicing and transcript stabilization. RBM41 binding hinders the recruitment of the spliceosome components necessary for correct intron excision, ultimately stalling the maturation process and promoting the accumulation of aberrant RNA species subject to degradation.

This mechanistic insight brings to the fore a sophisticated layer of gene expression regulation, where an RNA binding protein can pivotally dictate tumor suppressor gene output through modulation of RNA processing. It challenges previous assumptions that primarily focused on transcriptional regulation and post-translational modifications in cancer biology, shining light on RNA metabolism as a fertile ground for oncogenic manipulation.

The therapeutic implications of targeting RBM41 in colorectal cancer are profound. By designing small molecules or antisense oligonucleotides capable of disrupting the RBM41-pre-mRNA interaction, there exists the potential to restore NDRG1 levels and revive its tumor-suppressive functions. Such approaches could complement existing therapeutic regimes that often falter due to resistance mechanisms. Importantly, selective inhibition of RBM41 may exert minimal off-target toxicity given its specific modus operandi within cancer cells, sparing normal tissue homeostasis.

Additionally, the research opens investigative pathways into whether RBM41 has analogous roles in other cancer types or disease contexts characterized by aberrant RNA processing. Understanding the broader physiological and pathological landscape of RBM41’s activity could reveal universal principles of RNA-mediated regulation and novel biomarkers for cancer diagnostics.

This study also prompts a reevaluation of the current RNA biology paradigms within oncology. It exemplifies how post-transcriptional processes, once relegated to supporting roles, are in fact pivotal determinants of cellular fate. It encourages the scientific community to adopt integrative multi-omic approaches that encompass RNA-protein interactions and splicing dynamics when deciphering cancer etiology.

Moreover, this discovery underscores the critical importance of pre-mRNA maturation as a vulnerable node susceptible to oncogenic exploitation. The interface between RNA processing machinery and RNA binding proteins like RBM41 may represent a hotspot for intervention, with the potential to simultaneously influence multiple signaling cascades through restoration of normal transcript landscapes.

The research team employed cutting-edge technologies, including RNA immunoprecipitation sequencing (RIP-seq) and CRISPR-mediated gene editing, to validate the functional consequences of RBM41 manipulation. These powerful tools facilitated a detailed interrogation of molecular events underpinning RBM41’s role, enabling precise mapping of biological outcomes ranging from RNA splicing defects to altered cellular phenotypes.

In summation, the identification of RBM41 as a key inhibitor of NDRG1 pre-mRNA maturation provides a novel molecular cog in the machinery of colorectal tumorigenesis. It substantially advances our comprehension of how RNA binding proteins can govern oncogenic pathways via RNA processing interference. This promising discovery paves the way for innovative therapeutic strategies aimed at restoring tumor suppressor gene functionality through modulation of RNA metabolism—a frontier that is rapidly emerging at the nexus of cancer research.

As colorectal cancer continues to pose formidable clinical challenges, this study offers renewed hope by illuminating an uncharted regulatory axis ripe for exploitation. Future research should prioritize the development of RBM41-specific inhibitors, elucidate the protein’s broader interactome, and assess the translational potential of these findings in diverse patient populations. Ultimately, these endeavors will be vital in transforming molecular insights into tangible clinical benefits for patients grappling with colorectal malignancies.

Subject of Research:
The role of RNA binding motif protein 41 (RBM41) in promoting colorectal cancer development by impeding the maturation of NDRG1 pre-mRNA.

Article Title:
RNA binding motif protein RBM41 promotes colorectal tumorigenesis by impeding the maturation of NDRG1 pre-mRNA.

Article References:
Liu, Y., Mu, J., Yu, J. et al. RNA binding motif protein RBM41 promotes colorectal tumorigenesis by impeding the maturation of NDRG1 pre-mRNA. Cell Death Discov. 12, 276 (2026). https://doi.org/10.1038/s41420-026-03197-6

Image Credits: AI Generated

DOI: 20 June 2026

UC Berkeley physicists have introduced phase contrast to the electron microscope, allowing scientists to see much smaller molecules

In a groundbreaking advance that bridges molecular biology and evolutionary science, researchers at The University of Osaka have unveiled a novel methodology to resurrect ancestral proteins, specifically rhodopsins, enabling direct experimental investigation of these ancient molecules. This work, published in ACS Omega, outlines an innovative sequence reconstruction technique that integrates structural information and attentively accounts for insertions and deletions in protein sequences — a crucial improvement over conventional alignment methods that struggle with highly variable protein domains.

Microbial rhodopsins constitute a diverse family of membrane-embedded proteins with critical biological functions, ranging from ion transport to photoreception. Despite sharing a common structural feature of seven transmembrane helices, these proteins exhibit remarkable functional diversity, largely attributed to extensive variation in their extramembrane domains. Traditional sequence alignment algorithms fall short in tracing their evolutionary trajectories, as they typically do not handle complex insertions and deletions (indels) effectively, especially in variable regions outside of transmembrane segments.

Addressing these challenges, the team led by Haruto Ishikawa and Yasuhisa Mizutani developed ConsistASR, a structure-guided and indel-aware sequence reconstruction pipeline. This approach leverages three-dimensional structural insight to inform sequence alignment, thereby improving the accuracy of reconstructing full-length ancestral rhodopsin proteins. By carefully modeling sequence variability in extramembrane domains, the researchers were able to faithfully infer ancestral sequences that maintain key structural and functional attributes.

Focusing on two subfamilies of microbial rhodopsins—schizorhodopsins and heliorhodopsins—the study successfully resurrected their ancestral versions and expressed these proteins in Escherichia coli. The functional assays revealed that the ancestral schizorhodopsin exhibited light-driven proton pumping activity, consistent with its modern descendants, whereas the ancestral heliorhodopsin lacked ion transport activity, perfectly aligning with the known characteristics of extant heliorhodopsins.

Notably, the ancestral schizorhodopsin protein exhibited the expected spectral properties and stability, signifying correct folding within the bacterial membrane environment. This functional proof of concept not only validates the reconstruction pipeline but also opens a window into the evolutionary dynamics that have shaped rhodopsin diversification over time. The ability to experimentally produce and assay these ancient proteins allows scientists to study evolutionary adaptations at a molecular level with unprecedented precision.

The significance of this work extends beyond just the rhodopsin family. The ConsistASR platform provides a powerful toolkit that can be generalized to reconstruct other ancestral proteins characterized by variable length sequences and complex indels. Such reconstructions are invaluable for evolutionary biology, synthetic biology, and protein engineering, providing empirical insights into how proteins have evolved to acquire new functions and properties.

This innovative integration of sequence, structural, and functional analysis reflects a broader trend in molecular evolution research, where computational biology synergizes with experimental validation to overcome traditional obstacles. As the genomic and structural databases continue to expand, methods like ConsistASR could revolutionize our understanding of protein evolution and functionality by enabling direct interrogation of ancient biomolecules.

The study also tackles a fundamental evolutionary biology question—how functional diversity arises within a protein family while preserving core structural frameworks. By showing that ancestral proteins can be reconstructed in full length and retain distinct biophysical and functional profiles, the research provides direct empirical evidence for evolutionary trajectories that have resulted in contemporary diversity.

Moreover, the expression of these ancestral rhodopsins in bacterial hosts exemplifies how modern synthetic biology tools can resurrect and characterize long-extinct molecular functions. This not only informs evolutionary theory but also offers potential applications in biotechnology, where ancestral proteins might possess unique stability or functional features suitable for industrial or medical purposes.

In practical terms, illuminating the evolutionary path of microbial rhodopsins aids in comprehending microbial adaptation to various ecological niches, given these proteins’ pivotal role in light-driven energy conversion and environmental sensing. Ancestral protein resurrection thus provides a tangible bridge connecting molecular structure, evolution, and ecological function.

The research was supported by the Japan Society for the Promotion of Science and involved meticulous data analysis strategies, combining phylogenetics, structural biology, and bioinformatics. It underscores the multidisciplinary nature of modern biological discovery, illustrating that resolving complex biological problems often requires integrating diverse scientific perspectives and technologies.

Ultimately, this powerful approach reinvigorates the field of ancestral protein research by not only surmounting critical technical obstacles but also by delivering concrete functional data that validate hypotheses about ancient protein behavior. The availability of the ConsistASR workflow to the broader scientific community encourages collaborative exploration of protein evolution and engineering, heralding a new era of experimentally validated molecular paleobiology.

Subject of Research:
Not applicable

Article Title:
Resurrecting Full-length Ancestral Schizorhodopsins and Heliorhodopsins with Structure-guided, Indel-aware Sequence Reconstruction

News Publication Date:
8-Jun-2026

Web References:
https://doi.org/10.1021/acsomega.6c03010

Image Credits:
Haruto Ishikawa

Keywords:
Molecular biology, Biomolecules, Amino acids, Biomolecular structure, Domain organization, Bacterial proteins, Ancient proteins, Membrane proteins, Extracellular domains

University of Queensland researchers have revealed how a problematic cell protein causes a birth defect in an embryo,